{"id":"W4414642437","doi":"10.1182/bloodadvances.2025017244","title":"Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in <i>FLT3</i> -mutated AML","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"RCPA Foundation; Blood Cancer UK; Astellas Pharma; National Cancer Research Institute; Servier; Amgen; Pfizer; Cancer Research UK; Royal College of Pathologists of Australasia","keywords":"Gemtuzumab ozogamicin; Midostaurin; Cytarabine; Myeloid leukemia; Cumulative incidence; Chemotherapy; Induction chemotherapy; Fms-Like Tyrosine Kinase 3; Concomitant","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001800351,0.0001335993,0.0003546556,0.0002232354,0.00004541469,0.000009760848,0.00005416416,0.00006387933,0.000007444564],"category_scores_gemma":[0.00007339572,0.0001060308,0.00001547834,0.0004904528,0.0002232399,0.0001303778,0.00004038433,0.0002480575,4.118595e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005864445,"about_ca_system_score_gemma":0.0001486066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009916416,"about_ca_topic_score_gemma":0.0000579168,"domain_scores_codex":[0.9990679,0.00004305184,0.0002485678,0.0002795063,0.0001578885,0.0002030542],"domain_scores_gemma":[0.999508,0.0001369565,0.00007456566,0.0001622407,0.00006259208,0.0000555982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01785803,0.00140774,0.4778684,0.00158992,0.0007255858,0.0001911343,0.003116253,0.0001999492,0.16829,0.001334833,0.0001360722,0.3272821],"study_design_scores_gemma":[0.07084681,0.002251125,0.6716025,0.002014011,0.0002772385,0.0002303665,0.002247908,0.0004927531,0.2413031,0.0003877276,0.007964001,0.0003825191],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933946,0.003502056,0.00007662112,0.001268589,0.00002470984,0.0004671084,0.000004016213,0.00003066936,0.001231682],"genre_scores_gemma":[0.99497,0.00284833,0.001570424,0.0001640205,0.00001905368,0.000008590994,0.00001190473,0.00001530197,0.0003924123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3268996,"threshold_uncertainty_score":0.432381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007209435744216486,"score_gpt":0.2814725213016392,"score_spread":0.2742630855574227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}